Answers are grounded in this paper and cite their sources.
A common gastrointestinal condition known as peptic ulcer disease (PUD) is marked by ulceration of the stomach and duodenal mucosa due to an imbalance between mucosal defensive and aggressive stimuli. PUD continues to be a major global health burden despite advancements in diagnosis as well as treatment, which results in major complications like perforation, gastrointestinal bleeding, and obstruction. Helicobacter pylori (H. pylori)infection and Non-steroidal anti-inflammatory drug (NSAID) use remain the main underlying causes, but genetics, lifestyle, physiological factors, and environmental factors may also play a role. Dysfunction of mucosal defence, increased acid and pepsin activity, decreased bicarbonate and mucus secretion, inflammation, oxidative stress and alteration in stomach mucosal blood flow are all aspects of the pathogenesis of PUD. With a focus on the basic pathophysiological mechanism behind PUD, this review provides a summary of the disease’s epidemiology and major risk factors. Mucosal protective medicines, proton pump inhibitors, and histamine H2-receptor antagonists. H.pylori eradication regimens and the management of NSAID-associated ulcers are some of the current diagnostic and therapeutic methods that are covered. Additionally, emphasized are emerging therapy approaches and preventive strategies are emphasized. Improved clinical outcomes, early diagnosis, and the prevention of coexisting conditions can all be made possible by a greater awareness of the intricate processes underlying PUD.
No takes yet. Share an insight, caveat, or question.
Gaur et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: